Xueqing Xia

2.8k citations

76 papers · 2.2k indexed · h-index 26

Impact in

Oncology top 2%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer

Papers in

Immunology 33
- Immune Cell Function and Interaction 15
- Immunotherapy and Immune Responses 13
- T-cell and B-cell Immunology 6
Oncology 37
- CAR-T cell therapy research 17
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 8

Co-authors: Shulin Li Jiemiao Hu Abhisek Mitra Arun SatelliJun YanDenada Dibra Jeffry J. Cutrera Lopa Mishra
Journals: Molecular Therapy (5 papers)Clinical Cancer Research (4 papers)Nature Communications (4 papers)Cancer Letters (4 papers)Cancer Research (4 papers)
Partner nations: United States China Taiwan

In The Last Decade

Xueqing Xia

71 papers receiving 2.1k citations

Peers

Countries citing papers authored by Xueqing Xia

Since Specialization

Citations

This map shows the geographic impact of Xueqing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Xia more than expected).

Fields of papers citing papers by Xueqing Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Xia. The network helps show where Xueqing Xia may publish in the future.

Co-authors

The 25 scholars most cited alongside Xueqing Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xueqing Xia Line = papers co-authored together Xueqing Xia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The impact of digital literacy on older adults’ utilization of community-based home care services: a cross-sectional study BMC Health Services Research ·Xueqing Xia, Mingbao Zhu	2025	1
2	Low‐Temperature Lithium Metal Batteries Achieved by Synergistically Enhanced Screening Li ⁺ Desolvation Kinetics Advanced Materials ·Fengyi Zhu, Jian Wang, Yongzheng Zhang, Haifeng Tu, Xueqing Xia, Jing Zhang, Haiyan He, Hongzhen Lin, Meinan Liu	2024	16
3	Ultrabright and stable top-emitting quantum-dot light-emitting diodes with negligible angular color shift Nature Communications ·Mengqi Li, Rui Li, Longjia Wu, Xiongfeng Lin, Xueqing Xia, Zitong Ao, Xiaojuan Sun, Xingtong Chen, Song Chen	2024	31
4	Luxury or normal goods? Evidence from the utilization of institutional care services for the disabled older adults in China Frontiers in Public Health ·Xueqing Xia, Quanlun Li	2024	0
5	Decoupling the Conductivity–Fluorescence Tradeoff of SnO₂ Nanocrystals for Efficient and Stable Quantum Dot Light‐Emitting Diodes Laser & Photonics Review ·Xueqing Xia, Xingtong Chen, Jiachen Xie, Xinrui Li, Song Chen	2024	3
6	FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells Nature Communications ·Qingnan Zhao, Jiemiao Hu, Ling‐Yuan Kong, Shan Jiang, Xiangjun Tian, Jing Wang, Rintaro Hashizume, Zhiliang Jia, Natalie W. Fowlkes, Jun Yan, Xueqing Xia, Sofia Yi, Long Dao, David Masopust, Amy B. Heimberger, Shulin Li	2023	16
7	Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma Clinical Cancer Research ·Qing Yang, Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Hoang Dao, Wendong Zhang, Sheng Zhang, Xueqing Xia, Richard Görlick, Shulin Li	2022	13
8	Preparation of MoS₂–Ag/g-C₃N₄ Composite for Rhodamine B Degradation NANO ·Tian Ma, Xueqing Xia, Chengbao Liu, Fei Tang, Tao Jin, Junchao Qian, Zhi‐Gang Chen	2021	2
9	FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation Nature Communications ·Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling-Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R. Eric Davis, Longfei Huo, Ganesh Rao, Shao‐Cong Sun, Stephanie S. Watowich, Amy B. Heimberger, Shulin Li	2019	91
10	T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors Clinical Cancer Research ·Jiemiao Hu, Chuang Sun, Chantale Bernatchez, Xueqing Xia, Patrick Hwu, Gianpietro Dotti, Shulin Li	2018	62
11	A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53 PLoS ONE ·Denada Dibra, Xueqing Xia, Mihai Gagea, Guillermina Lozano, Shulin Li	2018	8
12	Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases Cancer Immunology Research ·Jiemiao Hu, Chantale Bernatchez, Liangfang Zhang, Xueqing Xia, Eugenie S. Kleinerman, Mien‐Chie Hung, Patrick Hwu, Shulin Li	2017	21
13	Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells Cancer Letters ·Heming Li, Qing H. Meng, Hyangsoon Noh, Izhar Singh Batth, Neeta Somaiah, Keila E. Torres, Xueqing Xia, Ruoyu Wang, Shulin Li	2017	28
14	Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo Clinical Cancer Research ·Denada Dibra, Abhisek Mitra, Melisa Newman, Xueqing Xia, Jeffry J. Cutrera, Mihai Gagea, Eugenie S. Kleinerman, Guillermina Lozano, Shulin Li	2016	12
15	Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression Clinical Cancer Research ·Arun Satelli, Abhisek Mitra, Zachary Brownlee, Xueqing Xia, Seth Bellister, Michael J. Overman, Scott Kopetz, Lee M. Ellis, Qing H. Meng, Shulin Li	2014	190
16	Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells Cancer Research ·Arun Satelli, Abhisek Mitra, Jeffry J. Cutrera, Marcos Devarie, Xueqing Xia, Davis R. Ingram, Denada Dibra, Neeta Somaiah, Keila E. Torres, Vinod Ravi, Joseph A. Ludwig, Eugenie S. Kleinerman, Shulin Li	2014	131
17	Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells Biological Procedures Online ·Jiemiao Hu, Long Vien, Xueqing Xia, Laura Bover, Shulin Li	2014	8
18	Molecular Imprint of Enzyme Active Site by Camel Nanobodies Journal of Biological Chemistry ·Jiangwei Li, Lijie Xia, Youhong Su, Hong‐Chun Liu, Xueqing Xia, Qinxia Lu, Chunjin Yang, Kalbinur Reheman	2012	19
19	Candidate Genes Associated with Tumor Regression Mediated by Intratumoral Il-12 Electroporation Gene Therapy Molecular Therapy ·Shulin Li, Xueqing Xia, Francesca M Mellieon, Jianguo Liu, Stacy Steele	2004	24
20	Identification of Quantitative Trait Loci Controlling Levels of Radiation-Induced Thymocyte Apoptosis in Mice Genomics ·Michael M. Weil, Xueqing Xia, Yue Lin, L. Clifton Stephens, Christopher I. Amos	1997	10

About Xueqing Xia

Xueqing Xia is a scholar working on Immunology, Oncology, Biotechnology, Genetics and Genetics, having authored 76 papers that have together received 2.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (17 papers), Immune Cell Function and Interaction (15 papers), Virus-based gene therapy research (13 papers), Immunotherapy and Immune Responses (13 papers), Cancer Cells and Metastasis (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), T-cell and B-cell Immunology (6 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (733 citations), Cancer Research (309 citations), Biotechnology (161 citations) and Genetics (350 citations). Xueqing Xia has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Shulin Li, Jiemiao Hu, Abhisek Mitra, Arun Satelli, Jun Yan, Denada Dibra, Jeffry J. Cutrera, Lopa Mishra, Amy B. Heimberger and Ling-Yuan Kong. Their work appears in journals such as Molecular Therapy, Clinical Cancer Research, Nature Communications, Cancer Letters and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact